Literature DB >> 15979244

Pretreatment and during treatment risk factors for dropout among patients with substance use disorders.

John McKellar1, John Kelly, Alex Harris, Rudolf Moos.   

Abstract

OBJECTIVE: The aim of this study was to use pretreatment and treatment factors to predict dropout from residential substance use disorder program and to examine how the treatment environment modifies the risk for dropout.
METHOD: This study assessed 3649 male patients at entry to residential substance use disorder treatment and obtained information about their perceptions of the treatment environment.
RESULTS: Baseline factors that predicted dropout included younger age, greater cognitive dysfunction, more drug use, and lower severity of alcohol dependence. Patients in treatment environments appraised as low in support or high in control also were more likely to drop out. Further, patients at high risk of dropout were especially likely to dropout when treated in a highly controlling treatment environment.
CONCLUSION: Better screening of risk factors for dropout and efforts to create a less controlling treatment environment may result in increased retention in substance use disorder treatment.

Entities:  

Mesh:

Year:  2005        PMID: 15979244     DOI: 10.1016/j.addbeh.2005.05.024

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  33 in total

1.  A preliminary investigation of the relationship between dispositional mindfulness and eating disorder symptoms among men in residential substance use treatment.

Authors:  JoAnna Elmquist; Ryan C Shorey; Scott E Anderson; Gregory L Stuart
Journal:  Addict Res Theory       Date:  2016-06-30

2.  Association of Therapeutic Alliance with Outcomes Over Two Years in Youth and Family Service.

Authors:  Shari L Hutchison; Irina Karpov; Alina Bodea Crisan; Eric Hulsey; David Dan
Journal:  Community Ment Health J       Date:  2018-04-26

3.  Predictors of Mental Health Treatment Seeking and Engagement in a Community Mental Health Center.

Authors:  Ruth S Shim; Michael T Compton; Shun Zhang; Kristin Roberts; George Rust; Benjamin G Druss
Journal:  Community Ment Health J       Date:  2017-02-01

4.  Emerging adult age status predicts poor buprenorphine treatment retention.

Authors:  Zev Schuman-Olivier; Roger D Weiss; Bettina B Hoeppner; Jacob Borodovsky; Mark J Albanese
Journal:  J Subst Abuse Treat       Date:  2014-05-20

5.  Determination of Clinical and Socio-demographical Differences of Adolescents Applying to a Treatment Center with Family Encouragement or the Decision of the Probation Office and Determination of Predictive Factors in Maintaining Soberness among Probation Cases.

Authors:  Zeki Yüncü; Rezzan Aydin; Cahide Aydin; Burcu Özbaran; Sezen Köse
Journal:  Noro Psikiyatr Ars       Date:  2016-06-01       Impact factor: 1.339

Review 6.  Cognitive dysfunction in individuals with cocaine use disorder: Potential moderating factors and pharmacological treatments.

Authors:  James J Mahoney
Journal:  Exp Clin Psychopharmacol       Date:  2018-12-17       Impact factor: 3.157

7.  Older methadone patients achieve greater durations of cocaine abstinence with contingency management than younger patients.

Authors:  Lindsay Weiss; Nancy M Petry
Journal:  Am J Addict       Date:  2013-02-01

8.  Development and initial evaluation of the Brief Addiction Monitor (BAM).

Authors:  John S Cacciola; Arthur I Alterman; Dominick Dephilippis; Michelle L Drapkin; Charles Valadez; Natalie C Fala; David Oslin; James R McKay
Journal:  J Subst Abuse Treat       Date:  2012-08-14

9.  A Naturalistic Evaluation of a Group Intervention for Parents of Youth with Substance Use Disorders.

Authors:  Victoria Ameral; Amy Yule; James McKowen; Brandon G Bergman; Jessica Nargiso; John F Kelly
Journal:  Alcohol Treat Q       Date:  2019-07-01

10.  Is General or Alcohol-Specific Perceived Social Support Associated with Depression among Adults in Substance Use Treatment?

Authors:  Ryan C Shorey; Anne E Dawson; Ellen Haynes; Catherine Strauss; JoAnna Elmquist; Scott Anderson; Gregory L Stuart
Journal:  J Psychoactive Drugs       Date:  2016-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.